Back to Search Start Over

Plasma Ceramides and Sphingomyelins in Relation to Heart Failure Risk

Authors :
Rozenn N, Lemaitre
Paul N, Jensen
Andrew, Hoofnagle
Barbara, McKnight
Amanda M, Fretts
Irena B, King
David S, Siscovick
Bruce M, Psaty
Susan R, Heckbert
Dariush, Mozaffarian
Nona, Sotoodehnia
Source :
Circ Heart Fail
Publication Year :
2019

Abstract

BACKGROUND: Ceramides exhibit multiple biological activities that may influence the pathophysiology of heart failure. These activities may be influenced by the saturated fatty acid carried by the ceramide (Cer). However, the associations of different circulating Cer species, and their sphingomyelins (SM) precursors, with heart failure have received limited attention. METHODS AND RESULTS: We studied the associations of plasma Cer and SM species with incident heart failure in the Cardiovascular Health Study. We examined 8 species: Cer and SM with palmitic acid (Cer-16 and SM-16), species with arachidic acid (Cer-20 and SM-20), species with behenic acid (Cer-22 and SM-22) and species with lignoceric acid (Cer-24 and SM-24). During a median follow-up of 9.4 years, we identified 1179 cases of incident heart failure among 4249 study participants. In Cox regression analyses adjusted for risk factors, higher levels of Cer-16 and SM-16 were associated with higher risk of incident heart failure (Hazard ratio [HR] for one SD increase:1.25 [95% CI: 1.16–1.36] and 1.28 [1.18–1.40], respectively). In contrast, higher levels of Cer-22 were associated with lower risk of heart failure in multivariable analyses further adjusted for Cer-16 (HR: 0.85 [0.78–0.92]); and higher levels of SM-20, SM-22 and SM-24 were associated with lower risk of heart failure in analyses further adjusted for SM-16 (HRs: 0.83 [0.77–0.90], 0.81 [0.75–0.88], and 0.83 [0.77–0.90] respectively). No statistically significant interactions with age, sex, African American race, BMI or baseline coronary heart disease were detected. Similar associations were observed for heart failure with preserved (n=529) or reduced (n=348) ejection fraction. CONCLUSIONS: This study shows associations of higher plasma levels of Cer-16 and SM-16 with increased risk of heart failure and higher levels of Cer-22, SM-20, SM-22, and SM-24 with decreased risk of heart failure. CLINICAL TRIAL REGISTRATION: clinicaltrials.gov; unique identifier: NCT00005133.

Details

ISSN :
19413297
Volume :
12
Issue :
7
Database :
OpenAIRE
Journal :
Circulation. Heart failure
Accession number :
edsair.pmid..........edf2cf2b13f784dcd164008608efb6d4